TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biobank AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,751
|
15,368
|
13,249 |
Financial expenses |
28
|
33
|
34 |
Earnings before taxes |
1,907
|
392
|
956 |
Total assets |
14,719
|
15,307
|
15,280 |
Current assets |
12,883
|
12,773
|
12,490 |
Current liabilities |
2,171
|
2,639
|
2,680 |
Equity capital |
10,096
|
9,220
|
8,635 |
- share capital |
296
|
317
|
308 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.6%
|
60.2%
|
56.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.9%
|
2.6%
|
7.2% |
Return on assets (ROA) |
13.1%
|
2.8%
|
6.5% |
Current ratio |
593.4%
|
484.0%
|
466.0% |
Return on equity (ROE) |
18.9%
|
4.3%
|
11.1% |
Change turnover |
-599
|
1,708
|
-1,469 |
Change turnover % |
-4%
|
13%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.